Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Chan, W.-K.
Right arrow Articles by Chan, T.-F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chan, W.-K.
Right arrow Articles by Chan, T.-F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Q J Med 2000; 93: 125-127
© 2000 Association of Physicians

Correspondence

Thrombolysis for acute pulmonary embolism in Chinese patients

W.-K. Chan and T.-F. Chan

Division of Cardiology, Department of Medicine & Geriatrics, United Christian Hospital, Hong Kong

Sir,

Acute pulmonary embolism is potentially fatal unless treated early. Thrombolytic therapy is beneficial for patients with acute pulmonary embolism who are hypotensive and have arterial hypoxaemia1, and those who are clinically stable but with echocardiographic evidence of right heart failure.2 However, in the Pulmonary Embolism Registry, the rate of major bleeding was higher in patients receiving thrombolytic therapy (21%) than in those on anticoagulation treatment (7.8%). In one study examining risk factors associated with bleeding in patients receiving thrombolysis for pulmonary embolism,3 the relative risk of bleeding . . . [Full Text of this Article]

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?